Skip To Content

Nuclear Medicine

李東洙
李東洙
  • Department核医学科
  • Specialty  

Dr. Dong Soo Lee has been doing clinical researches in nuclear neurology and brain mapping and clinical nuclear cardiology researches. His main achievement ranged from establishment of efficacy of gated SPECT in the evaluation of bypass graft surgery or new treatment modality such as intracoronary autologous bone marrow stem cell therapy, via application of mapping technology to the pre-operative evaluation of epilepsy patients using FDG PET or ictal SPECT, to the application of PET studies in the understanding of brain pathologies in profound deafness. His recent researches extended from the above clinical ones into the topics of pre-clicnial molecular imaging studies such as cell differentiation imaging in vivo using microPET/ microMRI and optical imaging methods. Adopting the very recent progresses of nanotechonolgy, he has just started to do in vivo nano-imaging studies. ‘MicroRNA imaging in vivo’ is just one example of these pursuits.

姜建旭
姜建旭
  • Department核医学科
  • Specialty  

鄭載民
鄭載民
  • Department核医学科
  • Specialty  

CAREER: Jae Min Jeong is a Professor in the Department of Nuclear Medicine, Seoul National University (SNU) College of Medicine since 2005. He graduated from College of Pharmacy SNU in 1982, and had M.Sc. and Ph.D. degrees in the Lab of Biochemistry in the same University. Doctoral thesis was about radiolabeling of monoclonal antibodies and various radiopharmaceuticals with 99mTc. He had Post-Doc in NIH, U.S.A., where he studied about radiolabeling of antibodies and peptides with various radioisotopes under Dr. Chang H Paik’s supervision (1990~1993). RESEARCH: He has over 140 peer-reviewed publications in SCI journals and over 30 pending patents mostly in the field of radiopharmaceutical chemistry. He contributed to the construction of the first PET Lab in Korea in SNU Hospital, where he installed many radiopharmaceutical production systems such as [18F]FDG, [11C]methionine, [11C]acetic acid, [11C]raclopride, [11C]PK11195, [11C]PIB, [18F]fluoroflumazenil, [18F]FDOPA, [18F]FMISO, [13N]NH3, [15O]H2O, and so on. He developed therapeutic radiopharmaceuticals such as 188Re-lipiodol for liver cancer therapy, 188Re-tin colloid for rheumatoid arthritis therapy, and 188Re-HEDP for bone pain palliation. He also developed various 68Ga-labeled radioligands such as 68Ga-labeled amino acid derivatives for imaging various cancers, 68Ga-labeled nitroimidazole derivatives for imaging hypoxic tissues, 68Ga-cRGDyK for imaging angiogenesis, and 68Ga-NOTA-MSA for imaging inflammatory atherosclerosis. Recently, he developed a new preparation method of multimodal nanoparticles.  SOCIAL ACTIVITY: He is members of Society of Radiopharmaceutical Sciences (SRS), Society of Nuclear Medicine and Molecular Imaging (SNMMI), World Molecular Imaging Society (WMIS), World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), Korean Society of Nuclear Medicine (KSNM), Korean Chemical Society (KCS), Pharmaceutical Society of Korea, etc. He served as a Secretary General of ISRS 2013 in Jeju successfully. He is the founding president of Korean Society of Radiopharmaceuticals and Molecular Probes (KSRAMP, 2014). He is editorial boards of many journals including Nuclear Medicine and Biology and Journal of Nuclear Medicine, and is the first Editor-in-Chief of Journal of Radiopharmaceuticals and Molecular Probes.  AWARDS: Distinguished Service Award by Korean Radioisotope Association (2005); and Nuclear Medicine Academy Award by Korean SNM (2012).

千基正
千基正
  • Department核医学科
  • Specialty  

李載成
李載成
  • Department核医学科
  • Specialty  

Professor Jae Sung Lee received his bachelor’s degree of electrical engineering and PhD of biomedical engineering from Seoul National University (SNU), Seoul, Korea in 1996 and 2001, respectively. He then worked as a Postdoctoral Fellow of Radiology at John Hopkins University (JHU). In 2005, he joined SNU College of Medicine where he is currently a Professor of Nuclear Medicine and Biomedical Sciences. His early academic achievements are mainly related with the PET/SPECT imaging studies for understanding the energetics and hemodynamics in brain and heart. The most notable achievement of Dr. Lee’s group since the foundation of his own lab in SNU is the development of PET systems based on a novel photo-sensor, silicon photomultiplier (SiPM). He has published 7 book chapters and over 200 papers in peer-reviewed journals and received multiple research awards from various scientific societies. He serves as editorial and advisory board members for several international scientific journals. He was the MIC Program Chair of 2013 NSS/MIC/RTSD meeting held in Seoul and has served as the Emphasis Chair on Technology & Software Developments of 2013 and 2014 World Molecular Imaging Conferences. 

所有菜单

전체 검색

전체 검색